Detalles de la búsqueda
1.
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia.
Haematologica
; 104(1): 147-154, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30115656
2.
Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study.
Hematol Oncol
; 35(4): 497-503, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27530779
3.
Cytarabine dose for acute myeloid leukemia.
N Engl J Med
; 364(11): 1027-36, 2011 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-21410371
4.
Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison.
Blood
; 113(6): 1375-82, 2009 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-18988865
5.
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study.
Exp Hematol
; 89: 55-60.e6, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32781097
6.
Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial.
Haematologica
; 92(7): 928-35, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17606443
7.
Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial.
J Clin Oncol
; 30(24): 2946-55, 2012 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22802322
8.
Analysis of efficacy and prognostic factors of lenalidomide treatment as part of a Dutch compassionate use program.
Clin Lymphoma Myeloma Leuk
; 10(2): 138-43, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20371448
9.
Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study.
Blood
; 101(6): 2144-51, 2003 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12456509
Resultados
1 -
9
de 9
1
Próxima >
>>